Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Aphidius ervi Teratocytes Release Enolase and Fatty Acid Binding Protein Through Exosomal Vesicles.

Salvia R, Grimaldi A, Girardello R, Scieuzo C, Scala A, Bufo SA, Vogel H, Falabella P.

Front Physiol. 2019 Jun 19;10:715. doi: 10.3389/fphys.2019.00715. eCollection 2019.

2.

Impact of Grapevine Red Blotch Disease on Grape Composition of Vitis vinifera Cabernet Sauvignon, Merlot, and Chardonnay.

Girardello RC, Cooper ML, Smith RJ, Lerno LA, Bruce RC, Eridon S, Oberholster A.

J Agric Food Chem. 2019 May 15;67(19):5496-5511. doi: 10.1021/acs.jafc.9b01125. Epub 2019 May 6.

PMID:
31013081
3.

The medicinal leech as a valuable model for better understanding the role of a TLR4-like receptor in the inflammatory process.

Girardello R, Baranzini N, Molteni M, Rossetti C, Tettamanti G, de Eguileor M, Grimaldi A.

Cell Tissue Res. 2019 Aug;377(2):245-257. doi: 10.1007/s00441-019-03010-0. Epub 2019 Mar 27.

PMID:
30919048
4.

Grapevine Red Blotch Virus May Reduce Carbon Translocation Leading to Impaired Grape Berry Ripening.

Martínez-Lüscher J, Plank CM, Brillante L, Cooper ML, Smith RJ, Al-Rwahnih M, Yu R, Oberholster A, Girardello R, Kurtural SK.

J Agric Food Chem. 2019 Mar 6;67(9):2437-2448. doi: 10.1021/acs.jafc.8b05555. Epub 2019 Feb 19.

PMID:
30721055
5.

Polymyxins susceptibility tests: we need talk about a solution.

Girardello R, Cury AP, Franco MRG, Di Gióia TR, de Almeida JN Jr, de Araújo MRE, da Silva Duarte AJ, Rossi F.

Diagn Microbiol Infect Dis. 2019 May;94(1):103. doi: 10.1016/j.diagmicrobio.2018.09.018. Epub 2018 Nov 22. No abstract available.

PMID:
30558826
6.

AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech.

Baranzini N, Monti L, Vanotti M, Orlandi VT, Bolognese F, Scaldaferri D, Girardello R, Tettamanti G, de Eguileor M, Vizioli J, Taramelli R, Acquati F, Grimaldi A.

J Innate Immun. 2019;11(2):150-167. doi: 10.1159/000493804. Epub 2018 Oct 26. Review.

7.

Rapamycin and fasting sustain autophagy response activated by ischemia/reperfusion injury and promote retinal ganglion cell survival.

Russo R, Varano GP, Adornetto A, Nazio F, Tettamanti G, Girardello R, Cianfanelli V, Cavaliere F, Morrone LA, Corasaniti MT, Cecconi F, Bagetta G, Nucci C.

Cell Death Dis. 2018 Sep 24;9(10):981. doi: 10.1038/s41419-018-1044-5.

8.

Functional amyloidogenesis in immunocytes from the colonial ascidian Botryllus schlosseri: Evolutionary perspective.

Franchi N, Ballarin L, Peronato A, Cima F, Grimaldi A, Girardello R, de Eguileor M.

Dev Comp Immunol. 2019 Jan;90:108-120. doi: 10.1016/j.dci.2018.09.010. Epub 2018 Sep 17.

PMID:
30236880
9.

Temporal evolution of Acinetobacter baumannii ST107 clone: conversion of blaOXA-143 into blaOXA-231 coupled with mobilization of ISAba1 upstream occAB1.

Rodrigues-Costa F, Cayô R, Matos AP, Girardello R, Martins WMBS, Carrara-Marroni FE, Gales AC.

Res Microbiol. 2019 Jan - Feb;170(1):53-59. doi: 10.1016/j.resmic.2018.07.001. Epub 2018 Jul 9.

PMID:
30003961
10.

Colistin susceptibility testing and Vitek-2™: is it really useless?

Girardello R, Cury AP, Franco MRG, Di Gióia TR, de Almeida JN Jr, de Araújo MRE, da Silva Duarte AJ, Rossi F.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):309-311. doi: 10.1016/j.diagmicrobio.2018.03.019. Epub 2018 Apr 8. No abstract available.

PMID:
29731389
11.

Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?

Rossi F, Girardello R, Morais C, Cury AP, Martins LF, da Silva AM, Abdala E, Setubal JC, da Silva Duarte AJ.

Clinics (Sao Paulo). 2017 Oct;72(10):642-644. doi: 10.6061/clinics/2017(10)09.

12.

Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.

Zavascki AP, Girardello R, Magagnin CM, Antochevis LC, Maciel RA, Palmeiro JK, Gales AC.

Diagn Microbiol Infect Dis. 2018 Feb;90(2):134-138. doi: 10.1016/j.diagmicrobio.2017.10.006. Epub 2017 Oct 19.

PMID:
29150371
13.

A new cellular type in invertebrates: first evidence of telocytes in leech Hirudo medicinalis.

Pulze L, Baranzini N, Girardello R, Grimaldi A, Ibba-Manneschi L, Ottaviani E, Reguzzoni M, Tettamanti G, de Eguileor M.

Sci Rep. 2017 Oct 19;7(1):13580. doi: 10.1038/s41598-017-13202-9.

14.

Cellular responses induced by multi-walled carbon nanotubes: in vivo and in vitro studies on the medicinal leech macrophages.

Girardello R, Baranzini N, Tettamanti G, de Eguileor M, Grimaldi A.

Sci Rep. 2017 Aug 21;7(1):8871. doi: 10.1038/s41598-017-09011-9.

15.

Human recombinant RNASET2-induced inflammatory response and connective tissue remodeling in the medicinal leech.

Baranzini N, Pedrini E, Girardello R, Tettamanti G, de Eguileor M, Taramelli R, Acquati F, Grimaldi A.

Cell Tissue Res. 2017 May;368(2):337-351. doi: 10.1007/s00441-016-2557-9. Epub 2017 Jan 9.

PMID:
28070637
16.

Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years.

Rossi F, Girardello R, Cury AP, Di Gioia TS, Almeida JN Jr, Duarte AJ.

Braz J Infect Dis. 2017 Jan - Feb;21(1):98-101. doi: 10.1016/j.bjid.2016.09.011. Epub 2016 Nov 8.

17.

In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods.

Fehlberg LC, Nicoletti AG, Ramos AC, Rodrigues-Costa F, de Matos AP, Girardello R, Marques EA, Gales AC.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):422-427. doi: 10.1016/j.diagmicrobio.2016.08.015. Epub 2016 Aug 28.

PMID:
27638346
18.

The polymyxin B-induced transcriptomic response of a clinical, multidrug-resistant Klebsiella pneumoniae involves multiple regulatory elements and intracellular targets.

Ramos PI, Custódio MG, Quispe Saji GD, Cardoso T, da Silva GL, Braun G, Martins WM, Girardello R, de Vasconcelos AT, Fernández E, Gales AC, Nicolás MF.

BMC Genomics. 2016 Oct 25;17(Suppl 8):737.

19.

Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.

Girardello R, Visconde M, Cayô R, Figueiredo RC, Mori MA, Lincopan N, Gales AC.

Diagn Microbiol Infect Dis. 2017 Jan;87(1):37-44. doi: 10.1016/j.diagmicrobio.2016.10.011. Epub 2016 Oct 8.

PMID:
27776788
20.

Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo.

Principi E, Girardello R, Bruno A, Manni I, Gini E, Pagani A, Grimaldi A, Ivaldi F, Congiu T, De Stefano D, Piaggio G, de Eguileor M, Noonan DM, Albini A.

Int J Nanomedicine. 2016 Sep 1;11:4299-316. doi: 10.2147/IJN.S109950. eCollection 2016.

21.

Amino acid transporter B(0)AT1 (slc6a19) and ancillary protein: impact on function.

Margheritis E, Imperiali FG, Cinquetti R, Vollero A, Terova G, Rimoldi S, Girardello R, Bossi E.

Pflugers Arch. 2016 Aug;468(8):1363-74. doi: 10.1007/s00424-016-1842-5. Epub 2016 Jun 2.

PMID:
27255547
22.

Diversity of mechanisms conferring resistance to β-lactams among OXA-23-producing Acinetobacter baumannii clones.

Cardoso JP, Cayô R, Girardello R, Gales AC.

Diagn Microbiol Infect Dis. 2016 May;85(1):90-7. doi: 10.1016/j.diagmicrobio.2016.01.018. Epub 2016 Jan 26.

PMID:
26971181
23.

Extracellular matrix degradation via enolase/plasminogen interaction: Evidence for a mechanism conserved in Metazoa.

Grossi G, Grimaldi A, Cardone RA, Monné M, Reshkin SJ, Girardello R, Greco MR, Coviello E, Laurino S, Falabella P.

Biol Cell. 2016 Jun;108(6):161-78. doi: 10.1111/boc.201500095. Epub 2016 Feb 25.

PMID:
26847147
24.

Effects of Carbon Nanotube Environmental Dispersion on an Aquatic Invertebrate, Hirudo medicinalis.

Girardello R, Tasselli S, Baranzini N, Valvassori R, de Eguileor M, Grimaldi A.

PLoS One. 2015 Dec 4;10(12):e0144361. doi: 10.1371/journal.pone.0144361. eCollection 2015.

25.

Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms.

Ramos PI, Picão RC, Almeida LG, Lima NC, Girardello R, Vivan AC, Xavier DE, Barcellos FG, Pelisson M, Vespero EC, Médigue C, Vasconcelos AT, Gales AC, Nicolás MF.

BMC Genomics. 2014 Jan 22;15:54. doi: 10.1186/1471-2164-15-54.

26.

The main actors involved in parasitization of Heliothis virescens larva.

Grimaldi A, Tettamanti G, Congiu T, Girardello R, Malagoli D, Falabella P, Valvassori R, Ottaviani E, de Eguileor M.

Cell Tissue Res. 2012 Dec;350(3):491-502. doi: 10.1007/s00441-012-1503-8. Epub 2012 Oct 6.

PMID:
23053052
27.

Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.

Girardello R, Bispo PJ, Yamanaka TM, Gales AC.

J Clin Microbiol. 2012 Jul;50(7):2414-8. doi: 10.1128/JCM.06686-11. Epub 2012 May 2.

28.

Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study.

Gales AC, Azevedo HD, Cereda RF, Girardello R, Xavier DE; INVITA-A-DORI Brazilian Study Group.

Braz J Infect Dis. 2011 Nov-Dec;15(6):513-20.

29.

Antimicrobial activity of ceftobiprole against gram-negative and gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study.

Cereda RF, Azevedo HD, Girardello R, Xavier DE, Gales AC; INVITA-A-CEFTO Brazilian Study Group.

Braz J Infect Dis. 2011 Jul-Aug;15(4):339-48.

30.

Low prevalence of blaOXA-143 in private hospitals in Brazil.

Werneck JS, Picão RC, Girardello R, Cayô R, Marguti V, Dalla-Costa L, Gales AC, Antonio CS, Neves PR, Medeiros M, Mamizuka EM, Elmor de Araújo MR, Lincopan N.

Antimicrob Agents Chemother. 2011 Sep;55(9):4494-5; author reply 4495. doi: 10.1128/AAC.00295-11. No abstract available.

31.

Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil.

Beirão EM, Furtado JJ, Girardello R, Ferreira Filho H, Gales AC.

Braz J Infect Dis. 2011 Jan-Feb;15(1):69-73.

32.

Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.

Xavier DE, Picão RC, Girardello R, Fehlberg LC, Gales AC.

BMC Microbiol. 2010 Aug 12;10:217. doi: 10.1186/1471-2180-10-217.

33.

Posatirelin for the treatment of degenerative and vascular dementia: results of explanatory and pragmatic efficacy analyses.

Gasbarrini G, Stefanini G, Addolorato G, Foschi F, Ricci C, Bertolotti P, Voltolini G, Bonavita E, Bertoncelli R, Renzi G, Bianchini G, Bonaiuto S, Giannandrea E, Cavassini G, Mazzini V, Chioma V, Marzara G, D'Addetta G, Totaro G, Dalmonte E, Tassini D, Giungi F, De Nitto C, Di Fazio G, Tessitore A, Guadagnino M, Tessitore E, Spina P, Luppi M, Bignamini A, Peracino L, Fiorentino M, Beun-Garbe D, Poli A, Ambrosoli L, Girardello R.

Arch Gerontol Geriatr. 1998 Jan-Feb;26(1):33-47.

PMID:
18653124
34.

Metabolism study of dihydro-alpha-ergocryptine,9,10-[9,10-3H(N)] in rat and human hepatocyte cultures and rat, monkey, and human microsomes.

Mas-Chamberlin C, Bromet N, Olgiati V, Girardello R, Lowenthal DT.

Am J Ther. 1997 Sep-Oct;4(9-10):291-9.

PMID:
10423622
35.

Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound.

Cesarone MR, Laurora G, DeSanctis MT, Incandela L, Fugazza L, Girardello R, Poli A, Peracino L, Ambrosoli L, Belcaro G.

Angiology. 1999 Jun;50(6):455-63.

PMID:
10378821
36.

The in vitro effect of Pidotimod on some immune functions in cancer patients.

Di Renzo M, Pasqui AL, Bruni F, Saletti M, Bova G, Chiarion C, Girardello R, Ferrì P, Auteri A.

Immunopharmacol Immunotoxicol. 1997 Feb;19(1):37-51.

PMID:
9049658
37.

Pharmacokinetic Study of Triflusal in Elderly Subjects After Single and Repeated Oral Administration.

Ferrari E, Reboldi G, Marenco P, D'Angelo L, Crema F, Ambrosoli L, Poli A, Girardello R, Lowenthal DT.

Am J Ther. 1996 Sep;3(9):630-636.

PMID:
11862303
38.

Pharmacokinetic profile and endocrine effects of posatirelin treatment in healthy elderly subjects.

Reboldi G, Parnetti L, Santeusanio F, Ambrosoli L, Palumbo B, Cherubini A, Girardello R, Poli A, Lowenthal DT, Senin U.

J Clin Pharmacol. 1996 Sep;36(9):823-31.

PMID:
8889903
39.

Pharmacokinetic and Metabolism Study in Healthy Volunteers After Administration of Single Oral Dose of (3)H-alpha-Dihydroergocryptine Mesylate.

Ronca F, Guazzelli M, Salvadori P, Palumbo R, Neuteboom B, Ambrosoli L, Poli A, Girardello R, Lowenthal DT.

Am J Ther. 1996 Aug;3(8):553-562.

PMID:
11862290
40.

Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placebo.

Parnetti L, Ambrosoli L, Agliati G, Caratozzolo P, Fossati L, Frattola L, Martucci N, Murri L, Nappi G, Puca FM, Poli A, Girardello R, Senin U.

Acta Neurol Scand. 1996 Jun;93(6):456-63.

PMID:
8836309
41.

Triflusal in the treatment of patients with chronic peripheral arteriopathy: multicentre double-blind clinical study vs placebo.

Auteri A, Angaroni A, Borgatti E, Catalano M, De Vizzi GB, Forconi S, Fossati L, Girardello R, Ambrosoli L, Poli A, et al.

Int J Clin Pharmacol Res. 1995;15(2):57-63.

PMID:
8593974
42.

Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients.

Coppi G, Silingardi S, Girardello R, De Aloysio D, Manzardo S.

J Chemother. 1993 Oct;5(5):302-6.

PMID:
8106903
43.

[Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].

Marelli P, Lupetti A, Senesi S, Uslenghi C, Girardello R, Campa M.

Drugs Exp Clin Res. 1993;19 Suppl:15-21. Italian. No abstract available.

PMID:
8625778
44.

Fibrinolytic enhancement in diabetic microangiopathy with defibrotide.

Belcaro G, Marelli C, Pomante P, Laurora G, Cesarone MR, Ricci A, Girardello R, Barsotti A.

Angiology. 1992 Oct;43(10):793-800.

PMID:
1476266
45.

Ex vivo evaluation of Pidotimod effect on immune response.

Pugliese A, Marinelli L, Forno B, Pollono AM, Uslenghi C, Girardello R.

Pharmacol Res. 1992 Sep;26 Suppl 2:178-9. No abstract available.

PMID:
1409298
46.

Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human neutrophils.

Capsoni F, Minonzio F, Ongari AM, Girardello R, Zanussi C.

Pharmacol Res. 1992 Sep;26 Suppl 2:172-3. No abstract available.

PMID:
1409296
47.

Activity and tolerability of tetridamine vaginal lavage in rats and women.

Manzardo S, Girardello R, Pinzetta A, Coppi G, De Aloysio D.

Boll Chim Farm. 1992 Mar;131(3):113-6.

PMID:
1418890
48.

An unusually prolonged case of heparin-induced thrombocytopenia and disseminated intravascular coagulation.

Castaman G, Ruggeri M, Girardello R, Rodeghiero F.

Haematologica. 1992 Mar-Apr;77(2):174-6.

PMID:
1398304
49.

Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod.

di Marco R, Condorelli F, Girardello R, Uslenghi C, Chisari G, di Mauro M, Speciale AM, Meroni PL, Nicoletti F.

Scand J Infect Dis. 1992;24(6):821-3.

PMID:
1287821
50.

Effects of a defibrotide-heparin combination on some measures of haemostasis in healthy volunteers.

Pogliani EM, Salvatore M, Fowst C, Girardello R, Marelli C.

J Int Med Res. 1989 Jan-Feb;17(1):36-40.

PMID:
2707475

Supplemental Content

Loading ...
Support Center